| Characteristic | Revenue in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
February 2025
More information
Region
Worldwide, United States
Survey time period
2009 to 2024
Supplementary notes
* For the fiscal year ended June 29.
** Perrigo changed its financial year from end of June to end of year. The transition period took place from June 28, 2015 to December 31, 2015. From 2016 on, the financial year lasts from January 1 to December 31.
*** During 2021, Perrigo sold its generics business. Previous years have not been restated.
Citation formats
